| UHC Commercial Medical & Drug | Catheter Ablation for Atrial Fibrillation – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Chromosome Microarray Testing (Non-Oncology Conditions) – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Cochlear Implants – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Cosentyx® (Secukinumab) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Cosmetic and Reconstructive Procedures – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Epidural Steroid Injections for Spinal Pain – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Gastrointestinal Disorders Diagnostic Procedures – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Gynecomastia Surgery – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Ilumya® (Tildrakizumab-Asmn) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Infertility Diagnosis, Treatment, and Fertility Preservation – Commercial and Individual Exchange Medical Policy | 2026-06-01 |